Mehri Jamilian, Mohammad Rafiei, Hamid Reza Jamilian, Azam Esmkhani,
Volume 14, Issue 6 (1-2012)
Abstract
Background: Noticing the significant role of fertility in Iranian families, the incidence of infertility and its social and cultural dimensions, this study was carried out to compare general health status of infertile women with fertile women.
Materials and Methods: This observational case-control study was done on 147 women as the control group and 147 infertile patients as the case group who were matched in terms of influential variables. Data collection was done through demographic questionnaire and general health questionnaire (GHQ) which were completed by both groups. The results were analyzed by logistic regression analysis, t test, and chi-square using STATA 10 software.
Results: Means of general health score in fertile and infertile women were 19.249.72 and 28.06 10, respectively. Here the mean score of the infertile women was significantly higher in comparison with the fertile women (p<0.001). Physical symptoms, anxiety, social interaction, and depression scores of infertile women were significantly higher in comparison with the fertile women (p<0.001). There were no significant differences in the means of age and duration of marriage between the two groups and the distribution of educational level, occupation, and income levels were the same in the two groups.
Conclusion: Average scores of general health and physical complaints, anxiety, impaired social interaction, and depression in infertile women were higher than those in fertile women. This indicates their involvement with some degrees of public health diseases.
Niloofar Agharezaee, Flora Forouzesh,
Volume 23, Issue 5 (11-2020)
Abstract
Background and Aim: Coronaviruses are a large family of viruses that cause disease in humans and animals. Coronavirus Disease 2019 (COVID-19) is an acute respiratory infectious disease caused by a new coronavirus. The World Health Organization has declared this infectious disease as a global pandemic.
Objective: This study aims to review the latest research advances in genetics, pathogenicity, and clinical features of COVID-19, as well as current therapies to combat this disease.
Methods & Materials: This is a systematic review study on articles published from 2010 to 2020 by searching in reputable databases such as PubMed, Scopus, Google Scholar, Web of Science, and ScienceDirect.
Ethical Considerations: Ethical principles have been observed in accordance with the guidelines of the National Ethics Committee and the COPE regulations.
Results: Examining the genome and genetic studies of the virus, it can be said that there are many similarities between different coronavirus types, but there are differences in their genomic and phenotypic structures that can affect their pathogenesis. Re-use of existing therapeutic drugs, previously designed for other infections and viral pathologies is currently the only practical approach to fight COVID-19. The tests for SARS-CoV-2 genome-specific vaccines and the therapeutic antibodies are currently being tested, but they require a long-term process and complete safety testing.
Conclusion: Rapid diagnosis of SARS-CoV-2 infection is the basis of disease control. There is currently no specific antiviral drug approved for SARS-CoV-2 infection. Therefore, preventive measures are necessary to stop and control the spread of COVID-19, according to genetic studies and the obtaining knowledge of the molecular mechanism of this virus.
